News

Press Releases

George Cintra, Senior-Level Neuromodulation Executive, Joins AdvaStim

April 5, 2017

Former CTO of Integer, joins AdvaStim to expand alliance partnerships and commercialization opportunities   BOSTON–(BUSINESS WIRE)–AdvaStim, Inc., www.advastim.com, a leading developer of ASIC-based technology platforms for neuromodulation therapies, announced today that George Cintra has joined the company as Strategic Advisor for Technology and […]

Read More »

Evergreen Medical Technologies Quadruples Size of Cleanroom Manufacturing Space for Implantable Medical Devices

February 22, 2017

Expanded ISO Class 7 and Class 8 Cleanroom Facilities Allow for Single-Source Manufacturing of Active Implantable Medical Devices SAINT PAUL, Minnesota, January 11, 2017:  Evergreen Medical Technologies, a leading developer of Class III active implantable medical devices and systems, today announced the […]

Read More »

Evergreen Medical Technologies Announces Collaboration with AdvaStim to Develop Next-Generation Neuromodulation Therapy Devices

June 2, 2015

SAINT PAUL, Minnesota, June 2, 2015:  Evergreen Medical Technologies today announced a collaboration agreement to design and develop next-generation, implantable neuromodulation therapy devices using Evergreen’s implantable device capabilities, combined with AdvaStim’s neuromodulation ASICoreTM and ASIControlTM technology platforms. Evergreen Medical Technologies, http://www.evergreenmedtech.com, designs, […]

Read More »

AdvaStim Expands Intellectual Property Portfolio with New Neurostimulation Patent

February 17, 2015

Integrated Switching Circuit and Pulse Generator Patent Advances AdvaStim’s Technology Aimed at Targeted Neurostimulation Therapies BEVERLY, Mass., February 17, 2015: AdvaStim, Inc., www.advastim.com, a leading developer of advanced technology platforms for neuromodulation therapies, announced today that the Company was issued a patent by […]

Read More »

AdvaStim Enters Neuromodulation Device Market

April 23, 2014

AdvaStim’s novel hardware and software platform gives developers capabilities to address current and emerging clinical indications. BEVERLY, Mass., April 23, 2014:  AdvaStim, Inc., www.advastim.com, a leading developer of advanced technology platforms for neuromodulation therapies, announced today that the Company has entered the […]

Read More »